[1] Mundlos S. The brachydactylies:a molecular disease family[J]. Clin Genet, 2009, 76(2):123-136. [2] Temtamy S A, Aglan M S. Brachydactyly[J]. Orphanet J Rare Dis, 2008, 3:15. [3] Lodder E M, Hoogeboom A J, Coert J H, et al. Deletion of 1 amino acid in Indian hedgehog leads to brachydactylyA1[J]. Am J Med Genet A, 2008, 146A(16):2152-2154. [4] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424. [5] Ma G, Yu J, Xiao Y, et al. Indian hedgehog mutations causing brachydactyly type A1 impair Hedgehog signal transduction at multiple levels[J]. Cell Res, 2011, 21(9):1343-1357. [6] Gao B, Guo J, She C, et al. Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1[J]. Nat Genet, 2001, 28(4):386-388. [7] Kirkpatrick T J, Au K S, Mastrobattista J M, et al. Identification of a mutation in the Indian Hedgehog (IHH) gene causing brachydactyly type A1 and evidence for a third locus[J]. J Med Genet, 2003, 40(1):42-44. [8] Liu Y, Ross J F, Bodine P V, et al. Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(beta) phosphorylation and promotes osteoblast differentiation and bone formation[J]. Mol Endocrinol, 2007, 21(12):3050-3061. [9] Oldridge M, Fortuna A M, Maringa M, et al. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B[J]. Nat Genet, 2000, 24(4):275-278. [10] Schwabe G C, Tinschert S, Buschow C, et al. Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B[J]. Am J Hum Genet, 2000, 67(4):822-831. [11] Hamamy H, Saleh N, Oldridge M, et al. Brachydactyly type B1:report of a family with de novo ROR2 mutation[J]. Clin Genet, 2006, 70(6):538-540. [12] Dong S, Wang Y, Tao S, et al. Mutation screening in candidate genes in four Chinese brachydactyly families[J]. Ann Clin Lab Sci, 2015, 45(1):94-99. [13] Hiremath M, Wysolmerski J. Parathyroid hormone-related protein specifies the mammary mesenchyme and regulates embryonic mammary development[J]. J Mammary Gland Biol Neoplasia, 2013, 18(2):171-177. [14] Klopocki E, Hennig B P, Dathe K, et al. Deletion and point mutations of PTHLH cause brachydactyly type E[J]. Am J Hum Genet, 2010, 86(3):434-439. [15] Pereda A, Garzon-Lorenzo L, Garin I, et al. The p.R56*mutation in PTHLH causes variable brachydactyly type E[J]. Am J Med Genet A, 2017, 173(3):816-819. [16] Thomas-Teinturier C, Pereda A, Garin I, et al. Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review[J]. Am J Med Genet A, 2016, 170(3):734-742. [17] Jamsheer A, Sowinska-Seidler A, Olech E M, et al. Variable expressivity of the phenotype in two families with brachydactyly type E, craniofacial dysmorphism, short stature and delayed bone age caused by novel heterozygous mutations in the PTHLH gene[J]. J Hum Genet, 2016, 61(5):457-461. [18] Page M M, Hooper A J, Glendenning P, et al. Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinic[J]. BMJ Case Rep, 2017, 2017:pii. [19] Vasques G A, Funari M F A, Ferreira F M, et al. IHH gene mutations causing short stature with nonspecific skeletal abnormalities and response to growth hormone therapy[J]. J Clin Endocrinol Metab, 2018, 103(2):604-614. |